Brief: Basilea Pharmaceutica FY Operating Income CHF 61.2 Million

Basilea Pharmaceutica AG, Allschwil

18/02/2025 06:15

Feb 18 (Reuters) - Basilea Pharmaceutica FY net income CHF 77.6 million.
* FY operating expenses CHF -147.4 million
* FY pretax profit CHF 60.3 million
* FY basic EPS CHF 6.42
* FY EPS CHF 5.83